In June 2017, there were 112 incidents of investment and financing in the global healthcare industry, including 19 mergers and acquisitions. Among them, domestic enterprises involved 34 investment and financing projects, covering 8 merger and acquisition events, the new three boards will increase 4 times, and 2 IPO listed companies. A total of 78 foreign investment and financing events occurred, including 11 mergers and acquisitions.
Overview
Compared with the investment and financing incidents in the global medical and health field in May 126, the number from June 112 has decreased relatively. However, in terms of the number of mergers and acquisitions in the industry, compared with the 12 mergers and acquisitions in May, 19 mergers and acquisitions occurred in June.
From the financing stage analysis, in June 2017, the financing stage of the global medical and health field was mainly concentrated in the A and B rounds, with 26 and 17 financing events respectively. Compared with last month's investment and financing, the proportion of early projects (Pre-A round, angel round, seed round) before the A round in June was generally lower, and the financing stage gradually became more obvious to the A round.
On the other hand, in fact, most of the financing still stays in the A round and the previous stage. A large number of early projects are sprouting under the incubation of capital, indicating that China has experienced a significant recovery after experiencing the so-called “capital winter†in 2016. Institutions and investors have begun to respond to the call of the country's "mass entrepreneurship, innovation" to provide financial assistance to small and medium-sized entrepreneurs.
China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.kangnewpharmas.com